• Oct 09 2026 This Week in Cardiology
    Oct 9 2026

    Listener feedback on POET II, sham control trials in atrial fibrillation, ICDs in HCM, and agenda laundering are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback

    POET II Response-Tailored or Standard-Duration ABX for Infectious Endocarditis

    • POET I Trial https://www.nejm.org/doi/10.1056/NEJMoa1808312
    • POET II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607887

    II PVI-SHAM-AF trial Back in the News

    • GAP-AF Trial https://www.ahajournals.org/doi/10.1161/circep.115.003337
    • PVI-SHAM-AF Trial 10.1016/S0140-6736(26)01558-8 External Link
    • Why Sham Studies Are a Sham in 2026 10.1016/j.hrthm.2026.09.056 External Link
    • The Indispensable Role of Sham Controls in Evaluating Interventional Therapies 10.1016/j.hrthm.2026.10.001 External Link

    III ICDs in HCM

    • I CDs for the Prevention of SCD in High-Risk Patients with HCM https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.078597
    • ICDs in HCM: Editorial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079687

    IV Agenda Laundering

    • How Commercial “Agenda Laundering” Shapes Critical Care https://www.bmj.com/content/395/bmj-2026-100963

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

    Show More Show Less
    29 mins
  • Oct 02 2026 This Week in Cardiology
    Oct 2 2026

    Listener feedback on DANISH-CRT, the POET II trial, a mechanistic study in obesity and AF, the DANCODE trial of slowing CAC progression, and more on GLP-1 drugs are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback

    • DANISH-CRT Trial 10.1016/S0140-6736(26)01597-7
    • Identifying LV Posterior Wall Delay in RBBB Using Lead V8 https://doi.org/10.1016/j.jacep.2026.03.009
    • Using Lead V8 as a Tool to Improve Patient Selection in CRT https://doi.org/10.1093/europace/euaf194

    II POET II Response-Tailored or Standard-Duration Antibiotics for Endocarditis

    • POET I https://www.nejm.org/doi/10.1056/NEJMoa1808312
    • POET II https://www.nejm.org/doi/full/10.1056/NEJMoa2607887

    III Obesity and AF – A Neat Study from the Team in Prague

    • LA Remodeling and Functional Maladaptations in Obesity https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.126.014509

    IV Reducing CAC: The DANCODE Trial

    • DANCODE Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.082363

    V Two Big RCTs of New GLP-1 Drugs

    • TRIUMPH-1 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2604169
    • SYNCHRONIZE-2 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607219

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    32 mins
  • Sep 25 2026 This Week in Cardiology
    Sep 25 2026

    Listener feedback, pulmonary embolism intervention, simple vs complex in BiV pacing, exercise in AF, and TAVR for paradoxical low-flow, low-gradient aortic stenosis are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback
    LBBP ICD Lead

    • LEADR LBBAP Trial https://pubmed.ncbi.nlm.nih.gov/41110529/

    TRIC-I-HF trial

    • TRIC-I-HF Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2606934
    • Growth of Tricuspid Interventions in Germany https://www.jacc.org/doi/10.1016/j.jcin.2025.05.030

    II Treatment of Acute Intermediate-High Risk PE – the PRAGUE-26 Trial

    • PRAGUE-26 Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2608012

    III Targeting CS leads in CRT devices – DANISH-CRT Trial

    • DANISH-CRT Trial 10.1016/S0140-6736(26)01597-7

    IV Exercise for AF, Especially When There Is LA Disease

    • Physical Activity and Risk of Incident AF in Atrial Cardiomyopathy https://www.jacc.org/doi/10.1016/j.jacadv.2026.102999

    V Paradoxical Low-Flow, Low-Gradient AS – REBOOT-PARADOX

    • REBOOT-PARADOX trial 10.1016/j.jacc.2026.08.017
    • ROTAS Trial https://heart.bmj.com/content/110/20/1223

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    34 mins
  • Sep 18 2026 This Week in Cardiology
    Sep 18 2026

    Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Correction on PROFID Trial

    II Listener Feedback

    III Fifth Universal Definition of MI

    • Fifth Universal Definition of MI https://doi.org/10.1093/eurheartj/ehag101
    • Foy/Mandrola Editorial on Troponin Use and Interpretation https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2777967

    IV New ESC HF Guidelines

    • ESC Guidelines for Management of HF https://doi.org/10.1093/eurheartj/ehag100
    • Sanjay Kaul on X https://x.com/kaulcsmc/status/2094959683215958158?s=20
    • Geographic Disparities in TOPCAT https://pmc.ncbi.nlm.nih.gov/articles/PMC5065247/

    V AIR STEMI Trial

    • AIR-STEMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2605373
    • CR Strategies After MI https://www.jacc.org/doi/10.1016/j.jacc.2024.04.051
    • PRAMI Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1305520
    • COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775
    • FULL REVASC Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2314149

    VI GLP-1 News – A SELECT Trial Secondary Analysis

    • Semaglutide and hsCRP in Patients with CVD and Obesity https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.074482

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    32 mins
  • Sep 11 2026 This Week in Cardiology
    Sep 11 2026

    A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Lp(a) Disappointment

    • HORIZON https://clinicaltrials.gov/study/NCT04023552
    • Press Release https://www.novartis.com/news/media-releases/novartis-announces-lpahorizon-phase-iii-topline-results-pelacarsen-patients-elevated-lpa-and-established-cardiovascular-disease-cvd
    • Rationale paper https://doi.org/10.1016/j.ahj.2025.03.019

    II FDA Clears AI-ECG for Acute MI Detection

    • Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio) 10.1016/j.ajem.2025.07.061
    • AI-Enabled ECG Analysis Improves Diagnostic Accuracy and Reduces False STEMI Activations: A Multicenter U.S. Registry https://www.jacc.org/doi/10.1016/j.jcin.2025.10.018
    • Queen of Hearts™ AI ECG App https://www.powerfulmedical.com/pmcardio-stemi/

    III TARGET CTCA Trial

    • Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain https://www.nejm.org/doi/10.1056/NEJMoa2608903

    IV CorCal trial

    • Press release https://www.escardio.org/news/press/press-releases/new-data-presented-on-the-use-of-coronary-artery-calcium-for-cardiovascular-risk-assessment/
    • CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics https://doi.org/10.1016/j.ahj.2026.107473

    V AMUNDSEN Trial

    • LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial InfarctionThe AMUNDSEN Randomized Clinical Trial https://jamanetwork.com/journals/jama/fullarticle/2853274

    VI TRIC-I-HF trial

    • Tricuspid Repair Cuts Death, HF Hospitalization in Severe TR https://www.medscape.com/viewarticle/tricuspid-repair-cuts-death-hf-hospitalization-severe-tr-2026a1000wvk
    • Tricuspid-Valve Intervention in Heart Failure https://www.nejm.org/doi/full/10.1056/NEJMoa2606934

    You May Also Like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    29 mins
  • Sep 04 2026 This Week in Cardiology
    Sep 4 2026

    ESC recaps on the SINGLE-AF trial, CMR Guide trial, two ATTR studies, PVI-SHAM-AF, STAREE, and an observational study of ICD benefit over the past decades are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I SINGLE-AF Trial

    To Anticoagulate or Not in Intermediate-Risk AF: The SINGLE-AF Trial https://www.medscape.com/viewarticle/anticoagulate-or-not-intermediate-risk-af-single-af-trial-2026a1000uko

    • SINGLE-AF https://www.nejm.org/doi/10.1056/NEJMoa2607978

    II Scar as an ICD risk stratifier

    Is Scar on CMR an Indication for ICD? CMR Guide Leaves Doubts

    https://www.medscape.com/viewarticle/scar-cmr-indication-icd-cmr-guide-leaves-doubts-2026a1000ukq

    • CMTR GUIDE Trial https://jamanetwork.com/journals/jama/fullarticle/2853395
    • MADIT II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa013474

    III Single vs Dual Therapy in ATTR-CM

    • HELIOS-B Trial Sub-analysis https://www.sciencedirect.com/science/article/pii/S0735109726072086
    • HELIOS-B Sub-analysis Editorial https://www.sciencedirect.com/science/article/pii/S0735109726073766#bib8
    • HELIOS-B main trial https://www.nejm.org/doi/10.1056/NEJMoa2409134
    • CARDIO-TTRansform Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2608510

    IV A Stunning Result of another Sham-controlled AF ablation trial

    Does AF Ablation Work? That's in Question After PVI-SHAM-AF https://www.medscape.com/viewarticle/does-af-ablation-work-s-question-after-sham-pvi-af-2026a1000uli

    • PVI-SHAM-AF Trial 10.1016/S0140-6736(26)01558-8 External Link
    • SHAM-PVI Trial https://jamanetwork.com/journals/jama/fullarticle/2823283
    • PFA-Sham Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079484

    V Should Older Adults Take Statins: The STAREE trial.

    STAREE Strengthens Case for Over-the-Counter Statins https://www.medscape.com/viewarticle/staree-strengthens-case-over-counter-statins-2026a1000vrw

    • STAREE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2607314

    VII Declining ICD Benefit After MI

    • Mortality Reduction with ICD for Prevention of SCD Post-MI https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag706/8768943
    • CONTEMP-ICD Trial https://clinicaltrials.gov/study/NCT06543446
    • PROFID-EHRA Trial https://profid-project.eu/profid-ehra-trial/

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    41 mins
  • Aug 28 2026 This Week in Cardiology
    Aug 28 2026

    Listener feedback on mechanical CPR devices, PFA and stroke, the Lindy effect in adopting new technology, and an ESC preview are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only.

    To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Listener Feedback on Mechanical Compression Devices for OHCA

    • Mechanical CPR Device Use and Cardiac Arrest Survival

    https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079272

    • PARAMEDIC trial https://www.thelancet.com/article/S0140-6736(14)61886-9/fulltext
    • CIRC trial https://www.resuscitationjournal.com/article/S0300-9572(14)00128-2/fulltext
    • LINC trial https://jamanetwork.com/journals/jama/fullarticle/1774037
    • Cochrane Review – Mechanical vs Manual Chest Compressions for Cardiac Arrest https://pmc.ncbi.nlm.nih.gov/articles/PMC6953326/

    II PFA and Stroke

    • Risk of Stroke and TIA With PFA vs RF Ablation https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.126.081092
    • AVANT GUARD Trial https://www.nejm.org/do/10.1056/NEJMdo008538/full/
    • EMBOL-AF Registry https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag217/8566008

    III A New ICD Lead

    • LEADR LBBAP Trial https://doi.org/10.1016/j.hrthm.2026.08.030

    IV ESC Preview

    • Mandrola's Preview of the European Society of Cardiology 2026 https://www.medscape.com/viewarticle/mandrolas-preview-european-society-cardiology-2026-2026a1000tfi

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    26 mins
  • August 21 2026 This Week in Cardiology
    Aug 21 2026

    Mechanical CPR devices, the dangers of AF performance measures, two scholarly articles on CLOSURE and CHAMPION, and a little ESC preview are the topics John Mandrola, MD, discusses in this week's podcast.

    This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

    https://www.medscape.com/twic

    I Mechanical Compression Devices for OHCA

    · Mechanical CPR Device Use Cardiac Arrest Survival

    https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.126.079272

    · PARAMEDIC Trial https://www.thelancet.com/article/S0140-6736(14)61886-9/fulltext

    · CIRC Trial https://www.resuscitationjournal.com/article/S0300-9572(14)00128-2/fulltext

    · LINC trial https://jamanetwork.com/journals/jama/fullarticle/1774037

    · Cochrane Review of Mechanical vs Manual Chest Compressions for Cardiac Arrest https://pmc.ncbi.nlm.nih.gov/articles/PMC6953326/

    II ACC AF Performance Measures

    · 2026 AHA/ACC Clinical Performance for Patients With AF https://www.jacc.org/doi/10.1016/j.jacc.2026.05.032#sec-3

    III Two Critical Appraisals of the recent LAAC trials

    · Reappraising CHAMPION-AF 10.1016/j.hrthm.2026.07.048 External Link

    · CHAMPION and CLOSURE: Reconciling Contrast Results https://doi.org/10.1093/eurheartj/ehag608

    ESC Early Preview

    · CMR Guide trial https://pmc.ncbi.nlm.nih.gov/articles/PMC6931571/

    · SINGLE AF Trial 10.1016/j.hroo.2025.12.008 External Link

    You may also like:

    The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

    Questions or feedback, please contact news@medscape.net

    Show More Show Less
    33 mins